BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SG2918 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SG2918\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07454187-3217@assetmemo.bio
DTSTAMP:20261121T005559Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:SG2918: Phase 1/2 readout est. (NCT07454187)
DESCRIPTION:SG2918\, phase 1/2\, Multiple Myeloma.\nStudy: To Evaluate the 
 Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma\nEs
 timated primary completion: 30 September 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/sg2918#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07454187
URL:https://assetmemo.bio/drug/sg2918#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
